GHB Dependent Changes in PEA-15 Gene Expression in Different Human Cell Lines GHB Dependent Changes in PEA-15 Gene Expression in Different Human Cell Lines
Main Article Content
Keywords
GHB, PEA-15, SH-SY5Y cells, THP-1 cells
Abstract
Background. Gamma-hydroxybutyric acid (GHB) is found to be present endogenously in mammalian brains. It has been abused increasingly in recent years, particularly in date rape sexual assaults. Metabolism of GHB happens very rapidly; it disappears within 12 hours, making its detection in criminal cases very complicated.
Aim. This study intended to determine whether PEA-15 gene expression in human cell lines can be used as a marker for expanding the window of GHB detection beyond 12 hours.
Methods. The effects of GHB on cell viability was determined by use of the MTT assay. Quantitative real-time PCR and western blots were used to assess the effect of GHB exposure on PEA-15 mRNA and protein levels respectively in human brain and blood cells.
Results. The viability of human brain cells was decreased as GHB concentrations increased. PEA-15 mRNA levels increased in 1321N1 and SH-SY5Y cells by 4.2- and 3.7-fold respectively, after a 100 µM GHB treatment (p<0.01 both), but with no change at 1µM GHB. However, PEA-15 mRNA levels were increased significantly in THP-1 cells by 40.8-fold after a 10 µM GHB treatment (p<0.01), but with no change at 900 µM GHB. PEA-15 protein expression levels were increased in THP-1 cells by 1.9- and 1.6-fold (p<0.001) after 10µM and 900µM GHB treatments respectively, and increased in SH-SY5Y cells by 1.6-fold (p<0.05) after a 100 µM GHB treatment. However, there were no changes in PEA-15 protein levels in SH-SY5Y cells after 24 hours of GHB exposure.
Conclusion. The results of this study on human cell lines support the previous study in mice, which suggests PEA-15 levels as a possible surrogate marker for GHB administration beyond 12 hours. Additional studies are required.
References
2. Bessman SP, Fishbein WN. Gamma-hydroxybutyrate, a normal brain metabolite. Nature. 1963 Dec;200(4912):1207.
3. Snead III OC, Morley BJ. Ontogeny of γ-hydroxybutyric acid. I. Regional concentration in developing rat, monkey and human brain. Dev Brain Res. 1981 Jul 1;1(4):579-89.
4. Caputo F, Vignoli T, Maremmani I, Bernardi M, Zoli G. Gamma-hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review. Int J Environ Res Public Health. 2009 Jun;6(6):1917-29.
5. Drasbek KR, Christensen J, Jensen K. Gamma‐hydroxybutyrate–a drug of abuse. Acta Neurol Scand. 2006 Sep;114(3):145-56.
6. Wisor JP, Morairty SR, Huynh NT, Steininger TL, Kilduff TS. Gene expression in the rat cerebral cortex: comparison of recovery sleep and hypnotic-induced sleep. Neuroscience. 2006 Jan 1;141(1):371-8.
7. Larson SJ, Putnam EA, Schwanke CM, Pershouse MA. Potential surrogate markers for gamma-hydroxybutyrate administration may extend the detection window from 12 to 48 hours. J Anal Toxicol. 2007 Jan 1;31(1):15-22.
8. Schnackenberg BJ, Saini UT, Robinson BL, Ali SF, Patterson TA. An acute dose of gamma-hydroxybutyric acid alters gene expression in multiple mouse brain regions. Neuroscience. 2010 Oct 13;170(2):523-41.
9. Kemmel V, Klein C, Dembélé D, Jost B, Taleb O, Aunis D, Mensah-Nyagan AG, Maitre M. A single acute pharmacological dose of γ-hydroxybutyrate modifies multiple gene expression patterns in rat hippocampus and frontal cortex. Physiol Genomics. 2010 Jan 26;41(2):146-60.
10. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005 Sep 15;390(3):729-35.
11. Kubes M, Cordier J, Glowinski J, Girault JA, Chneiweiss H. Endothelin induces calcium‐dependent phosphorylation of PEA‐15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem. 1998 Sep;71(3):1307-14.
12. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukaemia cell line (THP‐1). Int J Cancer. 1980 Aug 15;26(2):171-6.
13. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973 Nov 1;33(11):2643-52.
14. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978 Nov 1;38(11 Part 1):3751-7.
15. Clark RB, Su YF, Ortmann R, Johnson GL, Perkins JP. Factors influencing the effect of hormones on the accumulation of cyclic AMP in cultured human astrocytoma cells. Metabolism. 1975 Mar 1;24(3):343-58.
16. Kintz P, Goullé JP, Cirimele V, Ludes B. Window of detection of γ-hydroxybutyrate in blood and saliva. Clin Chem. 2001 Nov 1;47(11):2033-4.
17. Iovino S, Oriente F, Botta G, Cabaro S, Iovane V, Paciello O, Viggiano D, Perruolo G, Formisano P, Beguinot F. PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation. Cell Death Differ. 2012 Jul;19(7):1127.
18. Ramos-Miguel A, Esteban S, García-Sevilla JA. The time course of unconditioned morphine-induced psychomotor sensitization mirrors the phosphorylation of FADD and MEK/ERK in rat striatum: role of PEA-15 as a FADD-ERK binding partner in striatal plasticity. Eur Neuropsychopharmacol. 2010 Jan 1;20(1):49-64.
19. Formisano P, Perruolo G, Libertini S, Santopietro S, Troncone G, Raciti GA, Oriente F, Portella G, Miele C, Beguinot F. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumour development. Oncogene. 2005 Oct;24(47):7012.
20. Bifulco G, Miele C, Pellicano M, Trencia A, Ferraioli M, Paturzo F, Tommaselli GA, Beguinot F, Nappi C. Molecular mechanisms involved in GnRH analogue‐related apoptosis for uterine leiomyomas. Mol Hum Reprod. 2004 Jan;10(1):43-8.
21. Van Cauter E, Plat L, Scharf MB, Leproult R, Cespedes S, L'Hermite-Baleriaux M, Copinschi G. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest. 1997 Aug 1;100(3):745-53
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.